Mesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur la microsimulation - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Survival Rate »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Survival Analysis < Survival Rate < Survivors  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000044 (2013) Angela C. Tramontano [États-Unis] ; Lauren E. Cipriano ; Chung Yin Kong ; Jo-Anne O. Shepard ; Michael Lanuti ; G Scott Gazelle ; Pamela M. McmahonMicrosimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.
000045 (2013) Linda Battes [Pays-Bas] ; Isabella Kardys ; Rogier Barendse ; Ewout W. Steyerberg ; Masoud Amiri ; Marinus J C. Eijkemans ; Jaap W. Deckers ; Douwe Postmus ; Johanna J M. Takkenberg ; Ken Redekop ; Eric BoersmaMicrosimulation for clinical decision-making in individual patients with established coronary artery disease: a concept.
000081 (2012) E M Wever [Pays-Bas] ; J. Hugosson ; E A M. Heijnsdijk ; C H Bangma ; G. Draisma ; H J De KoningTo be screened or not to be screened? Modeling the consequences of PSA screening for the individual.
000102 (2012) Charles W. Drescher [États-Unis] ; Sarah Hawley ; Jason D. Thorpe ; Simone Marticke ; Martin Mcintosh ; Sanjiv S. Gambhir ; Nicole UrbanImpact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening.
000116 (2012) Iris Lansdorp-Vogelaar [Pays-Bas] ; Karen M. Kuntz ; Amy B. Knudsen ; Marjolein Van Ballegooijen ; Ann G. Zauber ; Ahmedin JemalContribution of screening and survival differences to racial disparities in colorectal cancer rates.
000137 (2011) N T Van Ravesteyn [Pays-Bas] ; E A M. Heijnsdijk ; G. Draisma ; H J De KoningPrediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals.
000215 (2009) Iris Lansdorp-Vogelaar [Pays-Bas] ; Marjolein Van Ballegooijen ; Ann G. Zauber ; J Dik F. Habbema ; Ernst J. KuipersEffect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
000244 (2008) Christopher Rao [Royaume-Uni] ; Jonathan Hart ; Andre Chow ; Fotios Siannis ; Polyxeni Tsalafouta ; Bari Murtuza ; Ara Darzi ; Frank C. Wells ; Thanos AthanasiouDoes preservation of the sub-valvular apparatus during mitral valve replacement affect long-term survival and quality of life? A Microsimulation Study.
000282 (2006) Iris Vogelaar [Pays-Bas] ; Marjolein Van Ballegooijen ; Deborah Schrag ; Rob Boer ; Sidney J. Winawer ; J Dik F. Habbema ; Ann G. ZauberHow much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment.
000306 (2004) M M Vervoort [Pays-Bas] ; G. Draisma ; J. Fracheboud ; L V Van De Poll-Franse ; H J De KoningTrends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality.
000325 (2002) J P Ouwens [Pays-Bas] ; H. Groen ; E M Tenvergert ; G H Koëter ; W J De Boer ; W. Van Der BijSimulated waiting list prioritization for equitable allocation of donor lungs.
000336 (2001) J J Takkenberg [Pays-Bas] ; M J Eijkemans ; L A Van Herwerden ; E W Steyerberg ; G L Grunkemeier ; J D Habbema ; A J BogersEstimated event-free life expectancy after autograft aortic root replacement in adults.
000339 (2000) J B Brown [États-Unis] ; A J Palmer ; P. Bisgaard ; W. Chan ; K. Pedula ; A. RussellThe Mt. Hood challenge: cross-testing two diabetes simulation models.
000357 (1998) M J Al [Pays-Bas] ; M A Koopmanschap ; P J Van Enckevort ; A. Geertsma ; W. Van Der Bij ; W J De Boer ; E M TenvergertCost-effectiveness of lung transplantation in The Netherlands: a scenario analysis.
000362 (1997) W K Evans [Canada]Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module.
000367 (1996) W K Evans [Canada] ; B P Will ; J M Berthelot ; M C WolfsonThe economics of lung cancer management in Canada.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=MicroSimulV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Survival Rate" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Survival Rate" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    MicroSimulV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Survival Rate
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sun Mar 10 17:35:57 2024. Site generation: Sun Mar 10 17:47:34 2024